{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:49Z","timestamp":1761059149436,"version":"3.32.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":933,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.jsps.2010.11.001","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T10:25:30Z","timestamp":1295432730000},"page":"9-17","source":"Crossref","is-referenced-by-count":5,"title":["Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients"],"prefix":"10.1007","volume":"19","author":[{"given":"A.","family":"Abdel-Bari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Sherif","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagwa Ali","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa Abd","family":"El-Shafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naglaa Samir","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2010.11.001_b0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01476-6","article-title":"Pharamacokinetic dosing of aminoglycosides: a controlled trial","volume":"114","author":"Bartal","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsps.2010.11.001_b0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/infdis\/132.2.165","article-title":"Predictability of blood levels of gentamicin in man","volume":"132","author":"Barza","year":"1975","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jsps.2010.11.001_b0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2125.1995.tb05719.x","article-title":"A suggested approach to once daily aminoglycoside dosing","volume":"39","author":"Begg","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl. C","key":"10.1016\/j.jsps.2010.11.001_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/27.suppl_C.91","article-title":"Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections","volume":"27","author":"Beucaire","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/AAC.8.1.58","article-title":"Gentamicin blood levels: a guide to nephrotoxicity","volume":"8","author":"Dahlgren","year":"1975","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0039-6060(98)70077-7","article-title":"Impact of altered aminoglycoside volume of distribution on the adequancy of a three milligram per kilogram loading dose","volume":"124","author":"Dorman","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.jsps.2010.11.001_b0035","article-title":"Do we still need the aminoglycosides?","author":"Durante-Mangoni","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.jsps.2010.11.001_b0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1179\/joc.1996.8.4.278","article-title":"Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a University Hospital in Saudi Arabia","volume":"8","author":"Eltahawy","year":"1996","journal-title":"J. Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.7326\/0003-4819-119-7_Part_1-199310010-00006","article-title":"Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia","volume":"119","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jsps.2010.11.001_b0050","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00003088-199120050-00003","article-title":"An updated comparison of drug dosing methods. Part III: Aminoglycosides antibiotics","volume":"20","author":"Erdman","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jsps.2010.11.001_b0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/jac\/39.6.677","article-title":"Once daily dosing of aminoglycosides: review and recommendations for the clinical practice","volume":"39","author":"Freeman","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. C","key":"10.1016\/j.jsps.2010.11.001_b0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/27.suppl_C.73","article-title":"Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections","volume":"27","author":"Giamarellou","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.jsps.2010.11.001_b0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/AAC.35.3.399","article-title":"Once daily aminoglycoside therapy","volume":"35","author":"Gilbert","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1177\/106002809302701104","article-title":"A practical alternative to conventional aminoglycoside dosing methods","volume":"27","author":"Goldman","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jsps.2010.11.001_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/07420529309059708","article-title":"Circadian variation in amikacin clearance and its effects on efficacy and toxicity in mice with and without immunosuppression","volume":"10","author":"Hosokawa","year":"1993","journal-title":"Chronobiol. Int."},{"issue":"9","key":"10.1016\/j.jsps.2010.11.001_b0080","first-page":"806","article-title":"Validation of computerized analytical systems. Installation and operational qualifications","volume":"14","author":"Huber","year":"1996","journal-title":"LC\u2013GC Magazine"},{"key":"10.1016\/j.jsps.2010.11.001_b0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.1988.83","article-title":"Aminoglycoside nephrotoxicity","volume":"33","author":"Humes","year":"1997","journal-title":"Kidney Int."},{"issue":"Suppl.","key":"10.1016\/j.jsps.2010.11.001_b0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/124.Supplement_1.S130","article-title":"Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States","volume":"124","author":"Jackson","year":"1971","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jsps.2010.11.001_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9343(96)80074-X","article-title":"Comparison of once daily versus pharmacokinetic dosing of aminoglycosides in elderly patients","volume":"101","author":"Jikoo","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsps.2010.11.001_b0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/129.2.187","article-title":"Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections","volume":"129","author":"Klastersky","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jsps.2010.11.001_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0924-8579(02)00030-4","article-title":"Extended interval aminoglycoside dosing. From concept to clinic","volume":"19","author":"Maglio","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jsps.2010.11.001_b0110","series-title":"Precis de Bacteriologie Clinique","first-page":"715","article-title":"Pharmacocinetiques\/parmacodynamie clinique des antibiotiques","author":"Maire","year":"2000"},{"key":"10.1016\/j.jsps.2010.11.001_b0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/22.1.75","article-title":"A study of amikacin given once versus twice daily in serious infections","volume":"22","author":"Maller","year":"1988","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.jsps.2010.11.001_b0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/FTD.0b013e3181570791","article-title":"An improved application for the enzyme multiplied immunoassay technique for caffeine, amikacin and methotrexate assays on the Dade-Behring dimension RXL max clinical chemistry system","volume":"29","author":"Mendu","year":"2007","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.jsps.2010.11.001_b0210","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1592\/phco.19.16.1252.30876","article-title":"Pharmacodynamic characterization of nephrotoxicity associated with once daily aminoglycoside","volume":"19","author":"Murry","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jsps.2010.11.001_b0125","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once daily aminoglycoside program administered to 2184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.jsps.2010.11.001_b0130","first-page":"2301","article-title":"Enzyme immunouassay of drug in blood (serum)","volume":"53","author":"Nishihara","year":"1995","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.jsps.2010.11.001_b0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/25.1.159","article-title":"Does the administration of an aminoglycoside in a single dose affect its efficacy and toxicity?","volume":"25","author":"Nordstrom","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0140","first-page":"381","article-title":"Circadian variations in the acute toxicity of three aminoglycosides: gentamicin, dibekacin, and netilmicin in mice","volume":"1","author":"Pariat","year":"1984","journal-title":"Annu. Rev. Chronopharmacol."},{"key":"10.1016\/j.jsps.2010.11.001_b0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-4274(88)90159-2","article-title":"Circadian variations in the renal toxicology of gentamicin in rats","volume":"40","author":"Pariat","year":"1988","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jsps.2010.11.001_b0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(93)90137-6","article-title":"Once versus thrice daily gentamicin in patients with serious infections","volume":"341","author":"Prins","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jsps.2010.11.001_b0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0009-9236(97)90156-9","article-title":"Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients","volume":"62","author":"Prins","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jsps.2010.11.001_b0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF02111864","article-title":"Intravenous administration of gentamicin once daily versus thrice daily in adults","volume":"14","author":"Raz","year":"1995","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.jsps.2010.11.001_b0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.43.7.1549","article-title":"Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity","volume":"43","author":"Rybak","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01086153","article-title":"Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients","volume":"4","author":"Sawchuk","year":"1976","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.jsps.2010.11.001_b0175","series-title":"Applied Pharmacokinetics","first-page":"174","article-title":"Aminoglycosides","author":"Schentagjj","year":"1980"},{"issue":"2","key":"10.1016\/j.jsps.2010.11.001_b0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/0147-7447-20050201-12","article-title":"Once daily aminoglycoside administration","volume":"28","author":"Trenika","year":"2005","journal-title":"Orthopedics"},{"issue":"3","key":"10.1016\/j.jsps.2010.11.001_b0185","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/GRF.0b013e31818091cd","article-title":"Once-daily dosing of gentamicin in obstetrics and gynecology","volume":"51","author":"Ward","year":"2008","journal-title":"Clin. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jsps.2010.11.001_b0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/106002809302700319","article-title":"Aminoglycoside dosing considerations in intensive care unit patients","volume":"27","author":"Watling","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jsps.2010.11.001_b0195","series-title":"Applied Pharmacokinetics","first-page":"331","article-title":"Aminoglycosides","author":"Zaske","year":"1986"},{"key":"10.1016\/j.jsps.2010.11.001_b0200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/AAC.21.3.407","article-title":"Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations","volume":"21","author":"Zaske","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jsps.2010.11.001_b0205","series-title":"A Textbook for the Clinical Application of Therapeutic Drug Monitoring","first-page":"285","article-title":"Antibiotics and other anti-infective agents: aminoglycosides","author":"Zaske","year":"1986"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016410000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016410000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:26:13Z","timestamp":1736184373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016410000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1319016410000939"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2010.11.001","relation":{},"ISSN":["1319-0164"],"issn-type":[{"type":"print","value":"1319-0164"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}